Arcadia Biosciences (RKDA) Change in Receivables (2016 - 2025)
Arcadia Biosciences' Change in Receivables history spans 12 years, with the latest figure at -$406000.0 for Q4 2025.
- For Q4 2025, Change in Receivables fell 228.08% year-over-year to -$406000.0; the TTM value through Dec 2025 reached -$165000.0, down 121.65%, while the annual FY2025 figure was -$165000.0, 121.65% down from the prior year.
- Change in Receivables reached -$406000.0 in Q4 2025 per RKDA's latest filing, down from -$176000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.4 million in Q1 2022 to a low of -$1.1 million in Q4 2022.
- Average Change in Receivables over 5 years is -$6950.0, with a median of $29000.0 recorded in 2021.
- Peak YoY movement for Change in Receivables: plummeted 15985.71% in 2022, then surged 1357.14% in 2024.
- A 5-year view of Change in Receivables shows it stood at -$7000.0 in 2021, then tumbled by 15985.71% to -$1.1 million in 2022, then surged by 105.77% to $65000.0 in 2023, then skyrocketed by 387.69% to $317000.0 in 2024, then plummeted by 228.08% to -$406000.0 in 2025.
- Per Business Quant, the three most recent readings for RKDA's Change in Receivables are -$406000.0 (Q4 2025), -$176000.0 (Q3 2025), and $224000.0 (Q2 2025).